Articles

Editorial

10.4244/EIJ-D-26-00289 May 4, 2026
Expanding physiology beyond the wire: will 2026 be the defining year?
Campo G, Biscaglia S
free

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N, Gonzalo N, Neylon A, Alfonso F
free

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S, Ortega-Paz L, Gomez-Lara J, Laudani C, Strosio M, Sabaté M
free

Original Research

10.4244/EIJ-D-25-01255 May 4, 2026
Quantitative flow ratio versus fractional flow reserve: 2-year follow-up of the FAVOR III Europe trial
Andersen B, Holm N, Sejr-Hansen M, Erriquez A, Råmunddal T, Stähli B, Guiducci V, Mogensen L, Westra J, Escaned J, Christiansen E, of the FAVOR III Europe investigators o

Original Research

10.4244/EIJ-D-25-01352 May 4, 2026
Derivation and external validation of a deep learning model to predict changes in coronary plaque burden
Garcia-Garcia H, Bulant C, Boroni G, Clausse A, Engstrøm T, Lemos P, Lecaros Yap N, Cap M, Iglesias J, Geuns R, Lang I, Spirk D, Häner J, Koskinas K, Kakizaki R, Ueki Y, Siontis G, Bourantas C, Blanco P, Räber L

Research Correspondence

10.4244/EIJ-D-25-01273 May 4, 2026
Drug-coated balloons for the treatment of coronary artery bypass graft failure
Marschall A, Chavez-Solsol J, Gonzalo N, Rivero F, Salinas P, Díez Del Hoyo F, Mejía-Rentería H, Escaned J, Alfonso F, Macaya-Ten F

Flashlight

10.4244/EIJ-D-25-01145 May 4, 2026
Natural history of coronary plaque redistribution after drug-coated balloon angioplasty
Dobrolińska M, Skorupski W, Kruk M, Dey D, Opolski M

Editorial

10.4244/EIJ-D-26-00300 Apr 20, 2026
Stable coronary patients with atrial fibrillation: when the kidneys tip the balance
Gilard M, Didier R
free

Viewpoint

10.4244/EIJ-D-25-01191 Apr 20, 2026
Aortic regurgitation: can transcatheter therapies deliver what we need?
Vahl T, Ranard L
free

Expert Review

10.4244/EIJ-D-25-01316 Apr 20, 2026
Electrosurgical laceration and stabilisation of tricuspid edge-to-edge repair: the ELASTA-T technique
Alvarez-Covarrubias H, Simonetti F, Mayr NP, Rheude T, Starnecker F, Xhepa E, Thilo C, Adam M, Joner M
free

Original Research

10.4244/EIJ-D-25-01274 Apr 20, 2026
Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial
Lee JM, Cho MS, Kang D, Ahn J, Oh Y, Lee CH, Choi E, Lee JH, Kwon CH, Park G-M, Choi HO, Park K, Park K, Hwang J, Yoo K, Cho Y, Kim JH, Hwang KW, Jin E, Kwon O, Kim K, Park S, Nam G, Park D

Clinical research

10.4244/EIJ-D-25-01328 Apr 20, 2026
Impact of device implantation depth on blood flow dynamics after left atrial appendage closure
Cepas-Guillén P, Albors C, Mill J, Aminian A, Garot P, De Backer O, Nielsen-Kudsk J, Iriart X, Barreiro-Perez M, Flores-Umanzor E, Cruz-González I, Arzamendi D, Avvedimento M, Nombela-Franco L, Leduc N, Horvilleur J, Kofoed K, Korsholm K, Cochet H, Estevez-Loureiro R, Barrouhou M, Lafond A, Millán X, Sanchis L, Rodés-Cabau J, Camara O, Freixa X

Trial Design

10.4244/EIJ-D-25-01307 Apr 20, 2026
No antithrombotic therapy versus single antiplatelet therapy after percutaneous left atrial appendage closure in non-valvular atrial fibrillation: rationale and design of the multicentre, randomised, non-inferiority NAPT-LAAC trial
Otsuka T, Yamamoto M, Asami M, Naganuma T, Ohno Y, Tani T, Nakazawa G, Izumo M, Saji M, Hachinohe D, Ueno H, Sugiura A, Shimura T, Okazaki S, Morikawa T, Izumi Y, Nakashima M, Kubo S, Shirai S, Watanabe Y, Hayashida K, of the OCEAN-LAAC investigators o
open access
Receive our newsletter


PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved